Key terms
About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NVO news
Yesterday
3:35am ET
Goldman Sachs Remains a Buy on Novo Nordisk (0QIU)
Nov 26
1:05pm ET
RBC sees little cause for concern over CMS’ proposed part D GLP-1 coverage rule
Nov 26
12:05pm ET
Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz
Nov 26
11:22am ET
Amgen (NASDAQ:AMGN) Sinks despite Positive MariTide Trial Data
Nov 26
11:07am ET
Novo Nordisk Stock Jumps on Biden Weight Loss Proposal Despite Upcoming Trump Presidency
Nov 26
10:40am ET
Weight loss drugmakers in spotlight as White House proposes coverage
Nov 26
10:10am ET
Trump Trade: Carmakers slip after 25% tariff threat on Mexico, Canada
Nov 26
9:20am ET
Amgen weight loss data ‘underwhelms,’ says Deutsche Bank
Nov 26
9:00am ET
White House proposes Medicare and Medicaid cover weight loss drugs
Nov 26
6:15am ET
Biden admin proposes obesity drugs covered by Medicare, Medicaid, NYTimes says
Nov 25
11:52am ET
Novo Nordisk Launches Major Share Repurchase Program
Nov 24
7:05am ET
Eli Lilly, others to buy after RFK-inspired drop, Barron’s says
Nov 22
2:25pm ET
Novo slated to win EU approval for Catalent takeover, Reuters says
Nov 18
11:48am ET
Novo Nordisk’s Ambitious Share Buyback Initiative
Nov 18
10:55am ET
UBS Sticks to Their Hold Rating for Novo Nordisk (0QIU)
Nov 15
3:25am ET
Goldman Sachs Sticks to Their Buy Rating for Novo Nordisk (0QIU)
Nov 14
6:31am ET
Novo Nordisk Executives Purchase ADRs on NYSE
Nov 13
9:57am ET
Bank of America Securities Sticks to Its Buy Rating for Novo Nordisk (NVO)
Nov 13
6:34am ET
Novo Nordisk Executives Engage in Share Transactions
Nov 11
10:05am ET
Novo Nordisk placed on ‘Positive Catalyst Watch’ at JPMorgan
Nov 11
9:35am ET
UBS Sticks to Their Hold Rating for Novo Nordisk (0QIU)
Nov 11
7:35am ET
Goldman Sachs Keeps Their Buy Rating on Novo Nordisk (0QIU)
Nov 11
7:34am ET
Buy Rating for Novo Nordisk: Strategic Growth and Market Opportunities Amid Supply Challenges
Nov 11
3:16am ET
J.P. Morgan Keeps Their Buy Rating on Novo Nordisk (0QIU)
Nov 08
5:28pm ET
Novo Nordisk Executives Sell Shares Worth DKK 4.74 Billion
Nov 08
5:18pm ET
Novo Nordisk Expands 2024 Share Repurchase Program
Nov 08
5:18pm ET
Novo Nordisk’s Strategic Share Repurchase Moves
Nov 08
5:18pm ET
Novo Nordisk Reports Insider Trading Activity
Nov 08
6:24am ET
Barclays Sticks to Their Buy Rating for Novo Nordisk (0QIU)
Nov 07
8:36pm ET
Novo Nordisk (0QIU) Gets a Hold from Kepler Capital
Nov 07
3:28pm ET
Novo Nordisk Executives Show Confidence with Share Purchases
Yesterday
8:00pm ET
AMGN Stock Down Despite Strong Data From Obesity Drug Study
Yesterday
2:46pm ET
LLY, NVO Stock Up as Biden Proposes Medicare Cover for Obesity Drugs
Nov 22
4:28pm ET
Novo Nordisk Plunges 25% in 3 Months: How to Play the Stock
Nov 22
2:18pm ET
VKTX Stock Loses Over $1B in a Month: How to Play the Stock?
Nov 21
4:40pm ET
PFE vs. NVO: Which Stock Is the Better Value Option?
Nov 21
1:24pm ET
Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
Nov 20
8:00pm ET
J&J Loses Around $24B in a Month: How to Play the Stock?
Nov 15
5:54pm ET
Trump Taps RFK for HHS: Time to Avoid Biotech?
Nov 15
3:08pm ET
AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?
Nov 14
8:00pm ET
Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate
Nov 13
12:48pm ET
Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus
Nov 12
2:45pm ET
Here's Why Novo Nordisk (NVO) is a Strong Growth Stock
Nov 11
8:00pm ET
Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?
Nov 11
11:20am ET
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Nov 07
1:50pm ET
TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase
Nov 06
8:00pm ET
Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings
Nov 06
4:49pm ET
NVO Misses Q3 Earnings & Revenue Estimates, Updates 2024 View
Nov 05
8:00pm ET
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
Nov 05
4:40pm ET
PFE or NVO: Which Is the Better Value Stock Right Now?
Nov 04
8:00pm ET
Buy, Sell or Hold Pfizer Stock After Q3 Earnings Beat, Guidance Boost?
Nov 04
2:30pm ET
Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
Nov 04
2:06pm ET
Novo Nordisk Before Q3 Earnings: How Should Investors Play the Stock?
Oct 31
12:43pm ET
Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus
Oct 30
4:49pm ET
Lilly's Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks
Oct 30
10:53am ET
The Zacks Analyst Blog Apple, Novo Nordisk, RTX and FONAR
Oct 29
9:19pm ET
Top Research Reports for Apple, Novo Nordisk & RTX
Oct 29
8:00pm ET
Can Mounjaro, Zepbound Help Eli Lilly Top Earnings Estimates Again?
Oct 29
5:15pm ET
Will Higher Expense Level Be a Woe for Humana in Q3 Earnings?
Oct 29
2:33pm ET
Zoetis Gears Up to Report Q3 Earnings: What's in the Offing?
Oct 28
10:45pm ET
Novo Nordisk (NVO) Stock Falls Amid Market Uptick: What Investors Need to Know
Oct 28
3:45pm ET
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?
NVO Financials
Key terms
Ad Feedback
NVO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
